Medication info
Liseron Plus Tablet

Liseron Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Genupharm Co., Ltd.
Appearance
Pale orange, oval film-coated tablet
Packaging
4 tablets (4 tablets/PTP packaging x 1)
Approval status
Active

MFDS item code 201606189 · Approved 2016.10.20 · Insurance code 698003310

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
1. Adults: Administer 1 tablet orally once weekly. 2. Elderly patients: No dosage adjustment is necessary in elderly patients (60 years of age and older), because the bioavailability and pharmacokinetics of this drug are similar to those in younger people. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or more. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this drug. To ensure adequate absorption, take it as follows: Take it at least 30 minutes before breakfast, or at any time of day provided it is taken at least 2 hours before or after food or beverages. Take this drug with an adequate amount of plain water (170 ~ 230ml) while sitting or standing upright to help it reach the stomach readily and reduce the possibility of esophageal irritation. Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking the drug. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, or patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this drug once weekly provides one week's supply of vitamin D at 800 IU per day. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Resume the usual schedule for the next dose. Do not take 2 tablets on the same day.
Child dose
3. Children: The safety and efficacy in children and adolescents who are still growing have not been established.

Ingredients

Manufacturer
Genupharm Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and in the treatment of osteoporosis in men.

How to take

Adult dose

1. Adults: Administer 1 tablet orally once weekly. 2. Elderly patients: No dosage adjustment is necessary in elderly patients (60 years of age and older), because the bioavailability and pharmacokinetics of this drug are similar to those in younger people. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or more. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this drug. To ensure adequate absorption, take it as follows: Take it at least 30 minutes before breakfast, or at any time of day provided it is taken at least 2 hours before or after food or beverages. Take this drug with an adequate amount of plain water (170 ~ 230ml) while sitting or standing upright to help it reach the stomach readily and reduce the possibility of esophageal irritation. Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking the drug. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, or patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this drug once weekly provides one week's supply of vitamin D at 800 IU per day. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Resume the usual schedule for the next dose. Do not take 2 tablets on the same day.

Child dose

3. Children: The safety and efficacy in children and adolescents who are still growing have not been established.

Precautions

This medication may irritate the gastric or esophageal mucosa, increasing the risk of problems like esophagitis and esophageal ulcers. After taking, it is essential to take it with a sufficient amount of water and not lie down for at least 30 minutes. Patients with esophageal issues or dysphagia should avoid this medication. Moreover, this drug requires supplementation if intake of calcium and vitamin D is insufficient, as it helps in treating osteoporosis. It is advisable not to take this medication simultaneously with other drugs or foods containing calcium, magnesium, iron, etc. Patients with severe renal disease or certain genetic metabolic abnormalities should not use this medication. Rarely, side effects such as skin rash, itching, muscle pain, joint pain, headache, and dyspepsia may occur. Women who are pregnant or breastfeeding must consult a doctor before taking this medication. It is not used in children as safety and efficacy have not been established.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • gastric ulcer
  • duodenitis
  • stomatitis
  • decreased serum calcium
Show 106 more
  • decreased serum phosphorus
  • infection
  • back pain
  • pain
  • abdominal pain
  • neck pain
  • weakness
  • chest pain
  • neoplasm
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal diseases
  • rectal diseases
  • dental diseases
  • petechiae
  • anemia
  • arthralgia
  • joint abnormalities
  • myalgia
  • bone pain
  • bone abnormalities
  • leg cramps
  • bursitis
  • tendon abnormality
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • tension increase
  • sensory disturbances
  • pharyngitis
  • rhinitis
  • breathlessness
  • pneumonia
  • rash
  • itching
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injuries due to accidents
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reactions
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • thirst
  • peripheral edema
  • traumatic fracture
  • myositis
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falling
  • influenza
  • uveitis
  • iritis
  • osteonecrosis of the jaw
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blisters
  • hypersensitivity reaction
  • liver dysfunction
  • jaundice
  • external auditory canal osteonecrosis
  • loss of appetite
  • discomfort in the chest
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • edema
  • hair loss
  • abnormal sense of smell
  • hypocalcemia
  • hypercalcemia
  • hypercalciuria
  • polyuria
  • thirst
  • weakness
  • drowsiness
  • atypical femoral fracture

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius. This will help preserve the efficacy of the medication for an extended period.

Appearance and packaging

Appearance

Pale orange, oval film-coated tablet

Package unit

4 tablets (4 tablets/PTP packaging x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.